CT News and Research

RSS

Bruker acquires SkyScan

Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.

2 Apr 2012

Galeterone safe, effective for patients with CRPC

Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.

2 Apr 2012

Tokai Pharmaceuticals announces data from galeterone Phase 1 trial for CRPC

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study.

2 Apr 2012

Metformin may slow growth rate of prostate cancer in men

The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the growth rate of the cancer, according to the results of a phase II study.

2 Apr 2012

$Pazopanib demonstrates clinically meaningful activity in patients with refractory urothelial cancer$

Pazopanib demonstrates clinically meaningful activity in patients with refractory urothelial cancer

The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. The results also revealed that increases in interleukin-8 levels early after treatment with pazopanib may predict a lack of tumor response to the therapy.

2 Apr 2012

Johns Hopkins Hospital's new home to open on May 1

The Johns Hopkins Hospital's new home, set to open on May 1, will redefine the very essence of the hospital experience, and cutting-edge technology designed to improve care, streamline workflow and encourage efficiencies will play a central role.

31 Mar 2012

CT scans more effective than traditional lung cancer detection methods

A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages.

31 Mar 2012

Perspectives: All this fuss about the word 'tax'; Civic lessons from the Supreme Court

It is now clear that the law will impose heavy burdens on state and family budgets and increasingly possible that its mandate that all Americans purchase health insurance or face penalties will be ruled unconstitutional. ... We and our Republican colleagues voted against the law two years ago and will continue to work toward a smarter, step-by-step solution that will make health care available to more Americans at a lower cost to the federal government, the states, and individuals seeking care.

31 Mar 2012

Fujifilm introduces Aspire CRm Full Field Digital Mammography system

FUJIFILM Medical Systems U.S.A., Inc. today unveiled the Aspire CRm Full Field Digital Mammography (FFDM) system, the latest addition to the company's expanding women's health offering. The Aspire CRm is an ideal option for smaller, stand alone breast imaging centers who want to easily transition from analog to digital imaging.

31 Mar 2012

Mirada Medical, BioClinica partner to extend oncology clinical trials

BioClinica, Inc., a global provider of clinical trial management solutions, today announced a partnership with Mirada Medical, a leading provider of medical image analysis software. BioClinica will integrate Mirada's XD3 software solution into its imaging core lab technology to further enhance its PET capabilities and expertise for molecular imaging trials.

From Clario 31 Mar 2012

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

Shire plc, the global specialty biopharmaceutical company, today announced top-line results of the PREVENT2 trial, a phase 3 investigational study of once-daily SPD476, MMX mesalamine in patients with a history of diverticulitis.

31 Mar 2012

Myths and facts about concussion

Suppose your son or daughter has just been brought home from an athletic field with a concussion, complains of being tired and wants to go to sleep. Should you let that happen? "There was a time when it was considered life-threatening to let someone suffering from a concussion to fall asleep," said Chris Hummel, a certified athletic trainer and clinical associate professor in Ithaca College's Department of Exercise and Sport Sciences.

30 Mar 2012

Patients with IBD, other GI disorders may be exposed to higher levels of diagnostic radiation

Patients with inflammatory bowel disease (IBD) and other gastrointestinal (GI) disorders may be exposed to significant doses of diagnostic radiation, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

30 Mar 2012

Perspectives on the court and the health law: Is this judicial activism?; Decision could define Roberts; Health economics 101

The ideological nature of the health care case was obvious on the last day of oral argument. By the time the proceedings were over, much of what the conservative justices said in court seemed like part of a politically driven exercise -; especially because the issues addressed on Wednesday were not largely constitutional in nature.

30 Mar 2012

Latest updates in clinical practice decision-making in cancer care presented at NCCN 17th conference

The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.

29 Mar 2012

Accidental ingestion of wire bristles leads to necessity for surgery

Rhode Island Hospital physicians identified six cases of accidental ingestion of wire grill brush bristles that required endoscopic or surgical removal. The paper calls attention to the need for the public and physicians to be aware of this potential danger.

29 Mar 2012

Southfield Capital acquires majority ownership of BioPharm

Southfield Capital, a private investment firm focused on the lower middle-market, announced today that it has acquired majority ownership of BioPharm Communications.

29 Mar 2012

Viewpoints: Why doctors find it hard to tell the truth; The fruits of biomedical research; Cheney's 'taxpayer-subsidized' benefits

Last month, an article in the journal Health Affairs made headlines in the news media -; "Physicians Are Not Always Open or Honest with Patients." A vast majority of the nearly 2,000 doctors surveyed agreed that physicians should be fully open and honest in all their communications with patients. ... I suspect that the dishonesty that is being uncovered in a study such as this -; and frankly, I was amazed that the number of less-than-truthful instances was so low -; reveals more about the diagnosis of being human than anything else. ... I couldn't bring myself to tell this young mother that she was going to die."

29 Mar 2012

Gene therapy improves chylomicron metabolism in LPLD patients

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today data demonstrating that one-time administration of the gene therapy Glybera (alipogene tiparvovec) is able to markedly improve chylomicron (fat particles in the blood) metabolism following consumption of a low fat meal.

29 Mar 2012